Quantbot Technologies LP Sells 171,978 Shares of American Healthcare REIT, Inc. (NYSE:AHR)

Quantbot Technologies LP cut its holdings in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 57.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 124,839 shares of the company's stock after selling 171,978 shares during the quarter. Quantbot Technologies LP owned 0.08% of American Healthcare REIT worth $3,548,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of AHR. Principal Financial Group Inc. grew its stake in shares of American Healthcare REIT by 54.1% in the 3rd quarter. Principal Financial Group Inc. now owns 9,488,750 shares of the company's stock worth $247,654,000 after buying an additional 3,330,714 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of American Healthcare REIT by 25.7% in the 3rd quarter. Wellington Management Group LLP now owns 13,445,752 shares of the company's stock valued at $350,934,000 after acquiring an additional 2,747,960 shares during the last quarter. State Street Corp grew its position in American Healthcare REIT by 221.6% in the third quarter. State Street Corp now owns 3,683,691 shares of the company's stock worth $96,473,000 after acquiring an additional 2,538,177 shares in the last quarter. FMR LLC purchased a new position in American Healthcare REIT in the third quarter worth about $56,575,000. Finally, Cbre Investment Management Listed Real Assets LLC bought a new stake in American Healthcare REIT during the fourth quarter worth approximately $33,838,000. Institutional investors own 16.68% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on AHR shares. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $34.00 price objective on shares of American Healthcare REIT in a research note on Wednesday, March 19th. JMP Securities set a $35.00 price target on American Healthcare REIT in a research report on Tuesday, March 4th. Citigroup reiterated an "outperform" rating on shares of American Healthcare REIT in a research report on Tuesday, March 4th. Finally, Morgan Stanley increased their target price on shares of American Healthcare REIT from $36.00 to $37.00 and gave the company an "overweight" rating in a research note on Tuesday. Seven equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $32.17.

Remove Ads

American Healthcare REIT Trading Down 1.6 %

AHR stock traded down $0.48 during midday trading on Wednesday, reaching $29.83. The company's stock had a trading volume of 3,153,565 shares, compared to its average volume of 1,650,080. American Healthcare REIT, Inc. has a 1 year low of $12.81 and a 1 year high of $30.97. The firm has a market capitalization of $4.70 billion and a price-to-earnings ratio of -62.15. The stock has a fifty day simple moving average of $28.88 and a two-hundred day simple moving average of $27.46. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.37 and a current ratio of 0.37.

American Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Monday, March 31st will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 3.35%. The ex-dividend date of this dividend is Monday, March 31st. American Healthcare REIT's dividend payout ratio is presently -370.37%.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.